| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.5 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.08 | 0.5 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |